Evidence map›Paper›PMID 37104339›Full record

ArticleTropical medicine and infectious disease2023

Scaling Up TB Screening and TB Preventive Treatment Globally: Key Actions and Healthcare Service Costs.

Srinath Satyanarayana, Carel Pretorius, Avinash Kanchar, Ines Garcia Baena, Saskia Den Boon, Cecily Miller, Matteo Zignol, Tereza Kasaeva, Dennis Falzon

Abstract read
In one paragraph

Article in Tropical medicine and infectious disease, 2023. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 7 papers.

0numbers the graph read from it
0cells of the map it votes in
7citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

7 citing papers in PubMed.

  1. Review
  2. Article
  3. Article
  4. Review
  5. Article
  6. Article
  7. Review
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

9 authors.

Srinath SatyanarayanaCentre for Operational Research, International Union against Tuberculosis and Lung Disease (The Union), New Delhi 110016, India.ORCID 0000-0002-5420-2551
Carel PretoriusCentre for Modelling and Analysis, Avenir Health, Glastonbury, CT 06033, USA.
Avinash KancharGlobal TB Programme (GTB), World Health Organization, 1211 Geneva, Switzerland.
Ines Garcia BaenaGlobal TB Programme (GTB), World Health Organization, 1211 Geneva, Switzerland.
Saskia Den BoonGlobal TB Programme (GTB), World Health Organization, 1211 Geneva, Switzerland.
Cecily MillerGlobal TB Programme (GTB), World Health Organization, 1211 Geneva, Switzerland.
Matteo ZignolGlobal TB Programme (GTB), World Health Organization, 1211 Geneva, Switzerland.
Tereza KasaevaGlobal TB Programme (GTB), World Health Organization, 1211 Geneva, Switzerland.
Dennis FalzonGlobal TB Programme (GTB), World Health Organization, 1211 Geneva, Switzerland.

Funding

World Health Organization 001
6 · The paper itself

Abstract

The 2018 United Nations High-Level Meeting on Tuberculosis (UNHLM) set targets for case detection and TB preventive treatment (TPT) by 2022. However, by the start of 2022, about 13.7 million TB patients still needed to be detected and treated, and 21.8 million household contacts needed to be given TPT globally. To inform future target setting, we examined how the 2018 UNHLM targets could have been achieved using WHO-recommended interventions for TB detection and TPT in 33 high-TB burden countries in the final year of the period covered by the UNHLM targets. We used OneHealth-TIME model outputs combined with the unit cost of interventions to derive the total costs of health services. Our model estimated that, in order to achieve UNHLM targets, >45 million people attending health facilities with symptoms would have needed to be evaluated for TB. An additional 23.1 million people with HIV, 19.4 million household TB contacts, and 303 million individuals from high-risk groups would have required systematic screening for TB. The estimated total costs amounted to ~USD 6.7 billion, of which ~15% was required for passive case finding, ~10% for screening people with HIV, ~4% for screening household contacts, ~65% for screening other risk groups, and ~6% for providing TPT to household contacts. Significant mobilization of additional domestic and international investments in TB healthcare services will be needed to reach such targets in the future.

Indexed as

active case findingcosts and cost analysisdiagnosislatent tuberculosis infectionprevention and controltuberculosis

Identifiers

PMID37104339
PMCPMC10144108

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.